FMC Corp extends credit facility to June 2028

PHILADELPHIA - FMC Corporation (NYSE:FMC), a chemical manufacturing company with a market capitalization of $4.6 billion, has amended its existing credit agreement, extending the termination date of its $2.0 billion revolving credit facility by one year to June 17, 2028. This extension was formalized through Amendment No. 4 to the Fifth Amended and Restated Credit Agreement originally dated June 17, 2022. According to InvestingPro data, FMC maintains a "Fair" financial health score, supported by strong profitability metrics and cash flow management.

The amendment, filed today with the Securities and Exchange Commission, enables FMC to maintain its substantial credit line with its consortium of lenders and issuing banks, with Citibank, N.A. continuing to serve as the administrative agent.

The extended credit facility is a key financial arrangement for FMC, providing the company with ongoing operational liquidity. The original agreement set the termination date for June 17, 2027, which has now been pushed to June 17, 2028, as per the recent amendment.

FMC Corporation has a range of financial relationships with the lenders involved in this credit facility, including cash management, investment banking, trust, leasing, and derivative services. These relationships encompass interest rate and foreign exchange arrangements with some of the lenders and their affiliates. Notably, FMC has maintained a strong track record of shareholder returns, with 19 consecutive years of dividend payments and a current dividend yield of 6.61%. For deeper insights into FMC’s financial health and valuation metrics, investors can access comprehensive analysis through InvestingPro’s detailed research reports.

This financial move comes as part of FMC’s broader strategy to secure its long-term financial stability and flexibility. The company, headquartered at 2929 Walnut Street, Philadelphia, PA, operates under the Chemicals & Allied Products industry with a Standard Industrial Classification (SIC) code of 2800.

The details of Amendment No. 4, including the terms and conditions of the credit facility, are available in the exhibits of the 8-K filing. This extension of the credit facility is now part of FMC Corporation’s direct financial obligations.

The information provided in this article is based on the most recent 8-K filing by FMC Corporation with the Securities and Exchange Commission.

In other recent news, FMC Corp has been the subject of several analyst revisions following its recent earnings report and future projections. Jefferies reduced its price target for FMC Corp to $49 but maintained a buy rating, despite the company’s mixed financial outlook. The firm noted FMC Corp’s Q4 earnings per share exceeded consensus, but its 2025 forecast fell short of expectations.

Meanwhile, UBS downgraded FMC Corp from buy to neutral and slashed its price target to $38, citing concerns over the company’s near-term prospects and potential long-term challenges. UBS’s revised 2025 EBITDA forecast for FMC is $877 million, a 14% reduction from previous estimates.

RBC Capital, Morgan Stanley (NYSE:MS), and BofA Securities also adjusted their view on FMC Corp. BofA downgraded the company from neutral to underperform and cut its price target to $48 due to concerns about FMC’s full-year guidance, competitive pressures, and the company’s leverage and dividend sustainability. Finally, Mizuho (NYSE:MFG) Securities maintained a neutral rating but reduced the price target to $51, following the company’s acknowledgment of broader challenges than initially expected. These recent developments indicate a cautious outlook for FMC Corp among analysts.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.